In other words, both pieces of evidence point to the notion that TRPML1 enhances the efficiency of cancer cells to execute malignant invasion and dissemination by promoting lysosomal ATP release into the extracellular space (Figure 1C), making it a prominent marker for therapeutic intervention, especially in metastatic cancers, such as TNBC. Here, MCOLN1 is linked to cancer.